Literature DB >> 18780861

Progress in the curative treatment of childhood hematologic malignancies.

Alan S Wayne, Gregory H Reaman, Lee J Helman.   

Abstract

Entities:  

Mesh:

Year:  2008        PMID: 18780861     DOI: 10.1093/jnci/djn306

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  13 in total

1.  Anti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia.

Authors:  Waleed Haso; Daniel W Lee; Nirali N Shah; Maryalice Stetler-Stevenson; Constance M Yuan; Ira H Pastan; Dimiter S Dimitrov; Richard A Morgan; David J FitzGerald; David M Barrett; Alan S Wayne; Crystal L Mackall; Rimas J Orentas
Journal:  Blood       Date:  2012-12-14       Impact factor: 22.113

2.  Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL): Overview and introduction to the proceedings of the 2016 TACL investigator meeting.

Authors:  Alan S Wayne; Erika Shin-Kashiyama; Richard Sposto; Paul Gaynon
Journal:  Pediatr Hematol Oncol       Date:  2017-11-09       Impact factor: 1.969

3.  Anti-CD22 immunotoxin RFB4(dsFv)-PE38 (BL22) for CD22-positive hematologic malignancies of childhood: preclinical studies and phase I clinical trial.

Authors:  Alan S Wayne; Robert J Kreitman; Harry W Findley; Glen Lew; Cynthia Delbrook; Seth M Steinberg; Maryalice Stetler-Stevenson; David J Fitzgerald; Ira Pastan
Journal:  Clin Cancer Res       Date:  2010-03-09       Impact factor: 12.531

Review 4.  Application of immunotherapy in pediatric leukemia.

Authors:  Alan S Wayne
Journal:  Curr Hematol Malig Rep       Date:  2009-07       Impact factor: 3.952

5.  Immunotoxin resistance via reversible methylation of the DPH4 promoter is a unique survival strategy.

Authors:  Hui Wei; Laiman Xiang; Alan S Wayne; Oleg Chertov; David J FitzGerald; Tapan K Bera; Ira Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-16       Impact factor: 11.205

Review 6.  Immunotherapy of childhood cancer: from biologic understanding to clinical application.

Authors:  Alan S Wayne; Christian M Capitini; Crystal L Mackall
Journal:  Curr Opin Pediatr       Date:  2010-02       Impact factor: 2.856

7.  A modified form of diphthamide causes immunotoxin resistance in a lymphoma cell line with a deletion of the WDR85 gene.

Authors:  Hui Wei; Tapan K Bera; Alan S Wayne; Laiman Xiang; Simona Colantonio; Oleg Chertov; Ira Pastan
Journal:  J Biol Chem       Date:  2013-03-13       Impact factor: 5.157

Review 8.  Immune-based therapeutics for pediatric cancer.

Authors:  Christian M Capitini; Crystal L Mackall; Alan S Wayne
Journal:  Expert Opin Biol Ther       Date:  2010-02       Impact factor: 4.388

9.  Immunotherapy for pediatric leukemia.

Authors:  Nirali N Shah; Hema Dave; Alan S Wayne
Journal:  Front Oncol       Date:  2013-07-01       Impact factor: 6.244

10.  Incidence of hospital-acquired pneumonia, bacteraemia and urinary tract infections in patients with haematological malignancies, 2004-2010: a surveillance-based study.

Authors:  Catherine Huoi; Philippe Vanhems; Marie-Christine Nicolle; Mauricette Michallet; Thomas Bénet
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.